# Boehringer Ingelheim (Germany)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/boehringer-ingelheim-germany/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 42.2 |
| Citations | 1,269,231 |
| City | Ingelheim |
| Country | DE |
| Description | Boehringer Ingelheim (Germany) is a research organisation in Ingelheim, DE. OpenAlex records 11,739 works and 1,269,231 citations for it. 3,462 researchers list it as their most recent affiliation. |
| Homepage | http://www.boehringer-ingelheim.de/ |
| OpenAlex ID | https://openalex.org/I1330995197 |
| Region | Rheinland-Pfalz |
| Researchers | 3,462 |
| ROR ID | https://ror.org/00q32j219 |
| Type | company |
| Works | 11,739 |

## University papers

Showing 12 of 103.

- [Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes](https://scholariq.org/papers/empagliflozin-cardiovascular-outcomes-and-mortality-in-type-2-diabetes/)
- [Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association](https://scholariq.org/papers/heart-disease-and-stroke-statistics-2020-update-a-report-from-the-american-heart/)
- [Heart Disease and Stroke Statistics—2021 Update](https://scholariq.org/papers/heart-disease-and-stroke-statistics-2021-update/)
- [Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure](https://scholariq.org/papers/cardiovascular-and-renal-outcomes-with-empagliflozin-in-heart-failure/)
- [Empagliflozin in Heart Failure with a Preserved Ejection Fraction](https://scholariq.org/papers/empagliflozin-in-heart-failure-with-a-preserved-ejection-fraction/)
- [Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes](https://scholariq.org/papers/empagliflozin-and-progression-of-kidney-disease-in-type-2-diabetes/)
- [Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression](https://scholariq.org/papers/genome-wide-association-analyses-identify-44-risk-variants-and-refine-the/)
- [Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials](https://scholariq.org/papers/effect-of-treatment-delay-age-and-stroke-severity-on-the-effects-of-intravenous/)
- [Guidelines for the Management of Adults with Community-acquired Pneumonia](https://scholariq.org/papers/guidelines-for-the-management-of-adults-with-community-acquired-pneumonia/)
- [Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility](https://scholariq.org/papers/multiple-sclerosis-genomic-map-implicates-peripheral-immune-cells-and-microglia/)
- [SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials](https://scholariq.org/papers/sglt2-inhibitors-in-patients-with-heart-failure-with-reduced-ejection-fraction-a/)
- [Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus](https://scholariq.org/papers/renal-hemodynamic-effect-of-sodium-glucose-cotransporter-2-inhibition-in/)

## University researchers

- [Peter Groß](https://scholariq.org/researchers/peter-gro/)
- [Bertil Waldeck](https://scholariq.org/researchers/bertil-waldeck/)
- [Dominik Steubl](https://scholariq.org/researchers/dominik-steubl/)
- [Efrat L. Amitay](https://scholariq.org/researchers/efrat-l-amitay/)
- [Anna Mazo](https://scholariq.org/researchers/anna-mazo/)
- [Egon Pfarr](https://scholariq.org/researchers/egon-pfarr/)
- [Anastasia Uster](https://scholariq.org/researchers/anastasia-uster/)

## University top topics

Showing 8 of 25.

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.